Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Regeneron Stock a Buy Now?

TheMotleyFool

0 0

Is Regeneron Stock a Buy Now?Photo, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Regeneron (NASDAQ: REGN) has been one of the better-performing biotech giants in the past year, with the company's shares rising by 33% in the past 12 months compared to the S&P 500's gains of about 9%. No doubt the drugmaker owes this performance in part to its coronavirus-related work. However, Regeneron is now facing severe headwinds in this market (more on that below).

Should investors still bet on this healthcare giant to continue outperforming the market?

REGN data by YCharts

Source Fool.com

Like: 0

REGN

Teilen